- Home
- ALLT vs FDMT Comparison
ALLT vs FDMT Comparison
Compare ALLT & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLT
- FDMT
- Stock Information
- Founded
- ALLT 1996
- FDMT 2013
- Country
- ALLT Israel
- FDMT United States
- Employees
- ALLT N/A
- FDMT N/A
- Industry
- ALLT Telecommunications Equipment
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- ALLT Telecommunications
- FDMT Health Care
- Exchange
- ALLT Nasdaq
- FDMT Nasdaq
- Market Cap
- ALLT 458.2M
- FDMT 391.8M
- IPO Year
- ALLT 2006
- FDMT 2020
- Fundamental
- Price
- ALLT $9.44
- FDMT $11.22
- Analyst Decision
- ALLT Strong Buy
- FDMT Strong Buy
- Analyst Count
- ALLT 3
- FDMT 9
- Target Price
- ALLT $12.75
- FDMT $30.11
- AVG Volume (30 Days)
- ALLT 340.7K
- FDMT 938.3K
- Earning Date
- ALLT 11-20-2025
- FDMT 11-07-2025
- Dividend Yield
- ALLT N/A
- FDMT N/A
- EPS Growth
- ALLT N/A
- FDMT N/A
- EPS
- ALLT N/A
- FDMT N/A
- Revenue
- ALLT $95,342,000.00
- FDMT $33,000.00
- Revenue This Year
- ALLT $10.42
- FDMT $9,656.76
- Revenue Next Year
- ALLT $13.06
- FDMT N/A
- P/E Ratio
- ALLT N/A
- FDMT N/A
- Revenue Growth
- ALLT 4.74
- FDMT N/A
- 52 Week Low
- ALLT $3.35
- FDMT $2.24
- 52 Week High
- ALLT $11.42
- FDMT $12.34
- Technical
- Relative Strength Index (RSI)
- ALLT 44.13
- FDMT 60.41
- Support Level
- ALLT $9.54
- FDMT $11.09
- Resistance Level
- ALLT $10.69
- FDMT $12.00
- Average True Range (ATR)
- ALLT 0.44
- FDMT 0.93
- MACD
- ALLT -0.10
- FDMT -0.03
- Stochastic Oscillator
- ALLT 17.65
- FDMT 58.82
About ALLT Allot Ltd.
Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. The company has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.